Viridian Therapeutics, Inc. (VRDN)

NASDAQ: VRDN · Real-Time Price · USD

14.68

+0.44 (3.09%)

At close: Jun 6, 2025, 4:00 PM

14.55

-0.13 (-0.89%)

After-hours: Jun 6, 2025, 6:53 PM EDT

Viridian Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jun '25 Jun 6, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	1,198	1,519	1,145	1,176	429	64	Upgrade
Market Cap Growth	-0.06%	32.58%	-2.58%	173.76%	568.00%	321.43%	Upgrade
Enterprise Value	584	977	989	892	379	44	Upgrade
Last Close Price	14.68	19.17	21.78	29.21	19.77	16.45	Upgrade
PS Ratio	3966.13	5028.17	3647.53	663.46	144.94	61.23	Upgrade
PB Ratio	2.88	2.26	2.59	2.98	2.29	0.54	Upgrade
P/TBV Ratio	2.88	3.15	4.86	4.65	7.97	-	Upgrade
EV/Sales Ratio	1934.58	3236.51	3150.76	503.65	127.79	41.48	Upgrade
Debt / Equity Ratio	0.04	0.03	0.05	0.01	0.00	0.00	Upgrade
Asset Turnover	0	0	0.00	0.01	0.02	0.01	Upgrade
Quick Ratio	18.88	14.99	17.93	12.73	14.48	11.96	Upgrade
Current Ratio	19.49	15.43	18.27	12.93	14.68	12.14	Upgrade
Return on Equity (ROE)	-51.95%	-48.48%	-56.80%	-44.57%	-51.61%	-163.07%	Upgrade
Return on Assets (ROA)	-32.62%	-30.32%	-34.37%	-26.28%	-29.75%	-31.36%	Upgrade
Return on Capital (ROIC)	-34.19%	-32.26%	-36.80%	-28.52%	-32.28%	-35.04%	Upgrade
Earnings Yield	-20.30%	-17.78%	-20.76%	-11.05%	-18.49%	-172.21%	Upgrade
FCF Yield	-23.41%	-15.33%	-16.16%	-8.05%	-12.79%	-46.39%	Upgrade
Buyback Yield / Dilution	-47.46%	-51.68%	-39.48%	-169.22%	-235.07%	-70.27%	Upgrade

Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q